FILING ANALYSIS · THURSDAY, NOVEMBER 12
AETHLON MEDICAL INC AEMD — 8-K: Results of Operations and Financial Condition
neutral
Aethlon Medical's 8-K filing announces a merger with North Immunology, Inc. and provides a corporate update, including financial results for the second quarter of fiscal 2027, with cash and cash equivalents of $6.5 million as of September 30, 2026, and operating expenses increasing 77.2% to $2.7 million due to higher professional fees associated with the proposed merger. The merger contemplates th
How we read impact: we grade every directional call in the open. Impact labels are AI estimates — not investment advice. See the full disclaimer.
Get filings like this every market day
The US SEC filings, UK RNS, EU notices, and Polymarket odds that matter — scored by AI, in one email.
Subscribe free →